South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Biocon Biologics, Civica partner to expand Insulin Aspart access in the US
Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...
News Medical on MSN19h
Mangoes may help reduce insulin resistance in adults who are overweight or obese
New research has uncovered a potential way to improve cardiometabolic health: fresh mangoes. A study recently published in ...
Biocon Biologics to supply Insulin Aspart drug substance to Civica for US market
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
New insights into insulin action: Dynamic signaling network offers therapeutic approaches for type 2 diabetes
Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...
The Financial Express3h
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...
EurekAlert!1d
New study: Eating mangos daily shown to improve insulin sensitivity and blood glucose control
New research finds mangos may be key to reducing insulin resistance, improving insulin sensitivity in adults who are ...